Document is current
Any future updates will be listed below
-
Authors
Jones, Sara E.
Harvey, Philip D. http://orcid.org/0000-0002-9501-9366
- License Information
-
More Information
Article History
Received: 11 January 2022
Revised: 15 March 2023
Accepted: 17 March 2023
First Online: 27 March 2023
Competing interests
: Last Year. Dr. Harvey has received consulting fees or travel reimbursements from Alkermes, Bio Excel, Boehringer Ingelheim, Karuna Therapeutics, Merck Pharma, Minerva Pharma, Roche Pharma, and Sunovion (DSP) Pharma in the past year. He receives royalties from the Brief Assessment of Cognition in Schizophrenia (Owned by WCG Verasci, Inc. and contained in the MCCB). He is chief scientific officer of i-Function, Inc. Dr. Jones has no Bomedical Conflicts of Interest to report.
